Primary Vitreoretinal Non-Hodgkin Lymphoma

Primary Vitreoretinal Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 1
Growth YoY: —
Industry share: 100%
Top sponsor: Aldeyra Therapeutics, Inc.
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07402876	A Clinical Trial Evaluating Patients With Primary Vitreoretinal Lymphoma	recruiting	Phase 3	20	Aldeyra Therapeutics, Inc.INDUSTRY	1	Feb 11, 2026	clinicaltrials
NCT05950490	Construction of Diagnosis and Treatment System for Primary Vitreoretinal Lymphoma	unknown	—	100	Peking Union Medical College HospitalOTHER	1	Jul 18, 2023	clinicaltrials